Source link : https://newshealth.biz/health-news/better-survival-in-refractory-crc-with-chemo-plus-bevacizumab-real-world-study-says/
(MedPage Today) — Overall survival (OS) in refractory metastatic colorectal cancer (mCRC) improved significantly with the addition of the VEGF inhibitor bevacizumab (Avastin) to chemotherapy, data from a real-world analysis showed. A propensity… Source link : https://www.medpagetoday.com/hematologyoncology/coloncancer/120069 Author : Publish date : 2026-02-26 21:45:00 Copyright for syndicated content belongs to the linked Source.
The post Better Survival in Refractory CRC With Chemo Plus Bevacizumab, Real-World Study Says first appeared on News Health.
—-
Author : News Health
Publish date : 2026-02-26 21:45:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8